Healthcare company-building profile
G4A Digital Health Partnerships
Bayer
AcceleratorPharma acceleratorCorporateActive
Source-based profile
Program at a Glance
- Program type
- Accelerator
- Program category
- Pharma accelerator
- Organization
- Bayer
- Organization type
- Corporate
- Location
- Whippany, New Jersey
- Company stage served
- Not publicly documented
- Cohort or participation model
- Annual partnership tracks (historically Advance and Growth tracks) rather than a fixed residential cohort
- Investment or funding offered
- Not publicly documented
- Published investment terms
- Not publicly documented
- Equity or fee model
- Not publicly documented
- Clinical or hospital connection
- Not publicly documented
- Application status
- Active
- Founded
- 2013
Public description
About the program
G4A is Bayer's digital health partnership and acceleration program, evolved from the earlier Grants4Apps accelerator into a structured partnership track for digital health companies. It combines funding, Bayer commercial and regulatory expertise and defined pilot pathways rather than a classic residential cohort. Bayer runs G4A globally with US activity anchored to its pharmaceutical business in New Jersey.
What the program publicly emphasizes
Focus areas and features
Digital healthDigital therapeuticsWomen's healthCardiology and renalOncologyRadiology AI
- Category: Pharma accelerator
- Program structure: Annual partnership tracks (historically Advance and Growth tracks) rather than a fixed residential cohort
Sources
External source links open in a new tab.